Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia

MeSH terms

• Adolescent
• Adult
• Combined Modality Therapy
• Dasatinib
• Disease-Free Survival
• Female
• Follow-Up Studies
• Fusion Proteins, bcr-abl / antagonists & inhibitors
• Hematopoietic Stem Cell Transplantation*
• Humans
• Male
• Middle Aged
• Philadelphia Chromosome*
• Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
• Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
• Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
• Protein Kinase Inhibitors / administration & dosage
• Protein Kinase Inhibitors / therapeutic use*
• Pyrimidines / administration & dosage
• Pyrimidines / therapeutic use*
• Remission Induction
• Secondary Prevention
• Thiazoles / administration & dosage
• Thiazoles / therapeutic use*
• Transplantation Conditioning*
• Transplantation, Autologous
• Transplantation, Homologous